Baxter International Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000BCVJ77
BAX
Baxter International Inc.
GICS: 35101010
·
Sector: Healthcare
·
Sub-Sector: Medical - Instruments & Supplies
NAME
Baxter International Inc.
ISIN
US0718131099
TICKER
BAX
MIC
XNYS
REUTERS
BAX.N
BLOOMBERG
BAX US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Tue, 04.03.2025
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, today unveiled Voalte Linq device powered by Scotty assistant, the company’s first voice-activated technology, at the 2025 HIMSS Global Healthcare Conference. Voalte Linq, a lightweight, wearable badge, is powered by Scotty assistant, a voice-activated technology, to better enable effi...
Baxter International
Tue, 25.02.2025
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be...
Baxter International
Thu, 20.02.2025
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its financial guidance for first-quarter and full-year 2025.
“Our 2024 performance and related strategic milestones reflect Baxter’s growing momentum in our pursuit of enhanced value for pati...
Baxter International
Tue, 18.02.2025
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:10 p.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be availab...
Baxter International
Mon, 17.02.2025
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates’ 46th Annual Institutional Investors Conference on Monday, March 3, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:05 p.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at ww...
Baxter International
Thu, 13.02.2025
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will...
Baxter International
Tue, 11.02.2025
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on April 1, 2025, to stockholders of record as of Feb. 28, 2025. The indicated annual dividend rate is $0.68 per share of common stock.
About...
Baxter International
Mon, 03.02.2025
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through Oct. 31, 2025.
The Baxter Board of Directors has appointed lead ...
Baxter International
Wed, 22.01.2025
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2024 financial results on Thursday, February 13, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I2823858 to pre-register for the call and rece...
Baxter International
Wed, 18.12.2024
Baxter International
US0718131099
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Joe) E. Almeida, Baxter's chair, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time.
The live webcast of Baxter’s presentation can be accessed a...
Baxter International
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
